PAR 3.77% 25.5¢ paradigm biopharmaceuticals limited..

Ann: Paradigm receives clarity on US regulatory pathway, page-56

  1. 1,224 Posts.
    lightbulb Created with Sketch. 177
    Thanks as well, my friend. ACKtually...One good engineer is much better than a few wanna be's! You are my designated Gifketeer, Sir!

    I think that the clarity-on-us-regulatory-pathway has been answered, but the remaining questions seem to be Retail vs Institutional opportunities. I am small potatoes with regards to this, and I am used to having Insto's and Banks (and politico's) getting in first, so it doesn't faze me as much as some here. But at least PAR now has what it needs to go forward and get this baby into market. Hopefully there will not be another hurdle put in the path.

    Happy Easter to all of those in observance...... and Happy Easter weekend to everyone else!
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.